Insider sales and mechanics
Andreas P. Wagner, Chief Human Resources Officer at Alignment Healthcare, Inc. (NASDAQ: ALHC), sold a total of 23,602 shares of the company's common stock across two trades that generated roughly $425,476 in total proceeds.
On March 18, 2026, Wagner disposed of 12,000 shares at a weighted-average price of $17.84, producing $214,080 in gross proceeds. The reported transaction price range for that lot was $17.40 to $18.24. The company filing states this sale was made to satisfy tax withholding obligations arising from the vesting of restricted stock units and was not a discretionary trade.
The following day, March 19, 2026, Wagner sold an additional 11,602 shares at a weighted-average price of $18.2207, yielding $211,396. Prices in that transaction ranged from $18.18 to $18.30. That sale was carried out pursuant to a pre-arranged 10b5-1 trading plan adopted on November 21, 2025.
Post-transaction ownership
After these two transactions, Wagner directly holds 148,628 shares of Alignment Healthcare common stock.
Market context and valuation notes
The stock is trading at $18.16. InvestingPro analysis cited in company commentary indicates that Alignment Healthcare is trading below its Fair Value estimate. InvestingPro Tips referenced in the filings show that analysts predict the company will be profitable in 2026, with an EPS forecast of $0.46 for that year. The firm has recorded strong top-line momentum, with revenue rising 46% over the last twelve months according to the same set of disclosures.
Recent operational and analyst updates
Alignment Healthcare reported a strong fourth-quarter performance highlighted by a 25% year-over-year increase in membership and a 44.4% increase in revenue, which exceeded expectations. Management reported a medical benefit ratio of 87.7% and an overall improvement in the selling, general, and administrative expense ratio to 9.7%.
Following those results, Raymond James reiterated a Strong Buy rating with a $27.00 price target, and Piper Sandler maintained an Overweight rating with a $30.00 price target.
Secondary offering and share supply
An affiliate of General Atlantic, L.P. announced a secondary offering of 13.2 million shares of Alignment Healthcare common stock at $19.46 per share. J.P. Morgan is listed as the underwriter for that offering. The disclosure notes the transaction will not provide any proceeds to Alignment Healthcare and that the offering is expected to close on March 4, 2026, subject to customary closing conditions.
Investor resources
For investors seeking additional analysis, the company note references a detailed Pro Research Report available on InvestingPro, covering this company and more than 1,400 other U.S. equities.
Conclusion
The transactions by Alignment Healthcare's CHRO combined a non-discretionary tax-withholding sale tied to vested restricted stock units and a planned sale executed under a 10b5-1 program. Those trades left Wagner with direct ownership of 148,628 shares while the company continues to be the subject of analyst coverage, reported quarterly strength, and a pending secondary offering from a strategic affiliate.
Note: This article relays details reported in company filings and analyst commentary referenced in those filings.